Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer: a plain language summary of the DESTINY-Breast03 study

Future Oncology, Ahead of Print.

Source: Future Oncology - December 7, 2023 Category: Cancer & Oncology Authors: Javier Cort és Source Type: research